← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $1.2M of BioMarin Pharmaceutical Inc.

Sold$1,248,854
$83.26Price
15,000Shares
−3%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Mar 16. Filed Tue, Mar 20. Not investment advice.